We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$82.5B
AUM Growth
+$5.26B
(+6.8%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-2.45%
Top 10 Holdings %
Top 10 Hldgs %
38.94%
Holding
962
New
129
Increased
342
Reduced
292
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$429M |
| 2 |
Airbnb
ABNB
|
+$235M |
| 3 |
T-Mobile US
TMUS
|
+$156M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$139M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deere & Co
DE
|
+$488M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$222M |
| 3 |
Expeditors International
EXPD
|
+$191M |
| 4 |
Qualcomm
QCOM
|
+$187M |
| 5 |
CERN
Cerner Corp
CERN
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.12% |
| 2 | Consumer Discretionary | 15.99% |
| 3 | Communication Services | 13.72% |
| 4 | Healthcare | 12.84% |
| 5 | Industrials | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Verizon
VZ
$196B
| $1.73M | ﹤0.01% |
30,890
+5,145
| +20% | +$295K |
|
|
ATVI
452
DELISTED
Activision Blizzard
ATVI
| $1.72M | ﹤0.01% |
18,005
+3,518
| +24% | +$333K |
|
453
Truist Financial
TFC
$64B
| $1.72M | ﹤0.01% |
30,908
+5,389
| +21% | +$317K |
|
454
Blackstone
BX
$110B
| $1.71M | ﹤0.01% |
+17,569
| New | +$1.56M |
|
|
ELAT
455
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $1.71M | ﹤0.01% |
+49,134
| New | +$2.47M |
|
456
Fox Class A
FOXA
$26.9B
| $1.7M | ﹤0.01% |
45,744
+26,223
| +134% | +$984K |
|
457
Energy Transfer Partners
ET
$69.3B
| $1.67M | ﹤0.01% |
+156,681
| New | +$1.5M |
|
458
Iron Mountain
IRM
$36.1B
| $1.62M | ﹤0.01% |
38,314
+38,115
| +19,153% | +$1.6M |
|
459
Organon & Co
OGN
$3.57B
| $1.6M | ﹤0.01% |
+53,031
| New | +$1.75M |
|
460
Intuit
INTU
$89B
| $1.5M | ﹤0.01% |
3,069
-608
| -17% | -$264K |
|
461
Unity
U
$18.9B
| $1.35M | ﹤0.01% |
+12,296
| New | +$1.21M |
|
|
BZUN
462
Baozun
BZUN
$172M
| $1.27M | ﹤0.01% |
35,917
+35,539
| +9,402% | +$1.25M |
|
463
McDonald's
MCD
$195B
| $1.16M | ﹤0.01% |
5,030
-6,591
| -57% | -$1.53M |
|
|
UMPQ
464
DELISTED
Umpqua Holdings Corp
UMPQ
| $1.09M | ﹤0.01% |
58,872
+57,837
| +5,588% | +$1.08M |
|
465
Vipshop
VIPS
$7.53B
| $1.08M | ﹤0.01% |
54,034
+17,114
| +46% | +$430K |
|
466
Credicorp
BAP
$30.7B
| $1.01M | ﹤0.01% |
8,306
-23
| -0.3% | -$3.01K |
|
467
iShares Russell 1000 Growth ETF
IWF
$128B
| $930K | ﹤0.01% |
13,700
-10,280
| -43% | -$663K |
|
468
Unilever
UL
$136B
| $868K | ﹤0.01% |
13,189
+424
| +3% | +$28.2K |
|
469
PayPal
PYPL
$50.5B
| $757K | ﹤0.01% |
2,597
+1,339
| +106% | +$354K |
|
470
Vanguard Morningstar Growth ETF
VUG
$230B
| $720K | ﹤0.01% |
15,054
-31,116
| -67% | -$1.41M |
|
|
471
CALL
Unity
U
$18.9B
| $681K | ﹤0.01% |
+6,200
| New | +$609K |
|
472
CoStar Group
CSGP
$12.3B
| $547K | ﹤0.01% |
6,610
+4,590
| +227% | +$397K |
|
473
Starwood Property Trust
STWD
$6.09B
| $498K | ﹤0.01% |
19,013
| – | – |
|
474
Citizens Financial Group
CFG
$30.6B
| $494K | ﹤0.01% |
10,765
+9,165
| +573% | +$433K |
|
475
Royal Caribbean
RCL
$85.6B
| $473K | ﹤0.01% |
5,552
+5,319
| +2,283% | +$464K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2021 Portfolio in Review
As of Q2 2021, Loomis, Sayles & Company held 962 positions worth $82.5B, up 6.8% from $77.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Loomis, Sayles & Company's Q2 2021 filing shows 129 new, 342 increased, 292 reduced and 136 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 946,065 shares worth $160M. The largest sale was Deere & Co, an estimated $488M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q2 2021 buy was Alnylam Pharmaceuticals: 946,065 shares worth $160M.
- Loomis, Sayles & Company added most to Vertex Pharmaceuticals in Q2 2021, an estimated $429M increase.
- Loomis, Sayles & Company's biggest Q2 2021 reduction was Deere & Co, cutting an estimated $488M.
- Loomis, Sayles & Company fully exited Goosehead Insurance in Q2 2021, selling an estimated $66.6M.
- Loomis, Sayles & Company's ten largest holdings make up 39% of its $82.5B portfolio in Q2 2021.
- Loomis, Sayles & Company opened 129 new positions and closed 136 in Q2 2021.
- Loomis, Sayles & Company's portfolio value rose 6.8% quarter-over-quarter to $82.5B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2021, filed 13 Aug 2021.